Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(11):1605–1612. doi: 10.1038/bjc.1997.274

Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation.

F Poirson-Bichat 1, G Gonfalone 1, R A Bras-Gonçalves 1, B Dutrillaux 1, M F Poupon 1
PMCID: PMC2223532  PMID: 9184175

Abstract

Methionine (MET) is required for cell metabolism. MET endogenously synthesized from homocysteine (HCY) supports the proliferation of normal cells, but not that of numerous malignant cells, as shown previously. MET starvation should have an anti-tumour effect, and its deleterious effects on the hosts might be prevented by HCY. Anti-tumour effects of MET starvation must be reinforced by ethionine (ETH), a MET analogue. MET dependency of PC-3, a human prostate cancer cell line, was studied in vitro. Proliferation of PC-3 cells, cultivated in MET-free medium, was 29% compared with growth in MET+HCY- medium. Addition of HCY to MET-free medium increased the proliferation rate to 56%. The concentration of ETH required to decrease the PC-3 cell proliferation rate to 50% (IC50) was 0.5 mg ml(-1) in MET-HCY- medium. ETH-induced inhibition was abolished by MET addition and was reinforced by HCY. PC-3 cell cycle was blocked in the S-G2-phase after 30 h culture in the absence of MET; this blockage was not reversed by addition of HCY. ETH at the IC50 in MET-HCY+ medium blocked DNA replication. Apoptotic cells appeared after 30 h incubation in MET-HCY+ medium only when ETH was added. ATP pools were decreased after 15 h of culture in MET-free medium. In vivo, MET starvation was obtained by feeding tumour-bearing mice a diet containing a synthetic amino acid mixture as the protein supply, in which HCY replaced MET. Given to nude mice bearing xenografted PC-3, from day 1 after grafting and for 3 weeks, this diet inhibited tumour growth (34% on day 20, P < 0.007); this effect was potentiated by ETH (200 mg kg(-1) day(-1) i.p.) (56% on day 20, P < 5 x 10(-5)). The differences between the effects of these two treatments were significant (P < 0.017) and optimal on day 20. These data showed that combination of ETH and HCY slowed the proliferation of prostate cancer cells in vitro and in vivo, decreased ATP synthesis and caused cell cycle arrest and apoptosis. Experimental therapy based on cancer cell MET metabolism deficiency could be efficient for treating advanced prostate cancers refractory to current therapies.

Full text

PDF
1605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boehm T. L., Drahovsky D. Elevated transcriptional complexity and decrease in enzymatic DNA methylation in cells treated with L-ethionine. Cancer Res. 1981 Oct;41(10):4101–4106. [PubMed] [Google Scholar]
  2. Borner M. M., Myers C. E., Sartor O., Sei Y., Toko T., Trepel J. B., Schneider E. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res. 1995 May 15;55(10):2122–2128. [PubMed] [Google Scholar]
  3. Bravard A., Sabatier L., Hoffschir F., Ricoul M., Luccioni C., Dutrillaux B. SOD2: a new type of tumor-suppressor gene? Int J Cancer. 1992 May 28;51(3):476–480. doi: 10.1002/ijc.2910510323. [DOI] [PubMed] [Google Scholar]
  4. Breillout F., Antoine E., Poupon M. F. Methionine dependency of malignant tumors: a possible approach for therapy. J Natl Cancer Inst. 1990 Oct 17;82(20):1628–1632. doi: 10.1093/jnci/82.20.1628. [DOI] [PubMed] [Google Scholar]
  5. Breillout F., Hadida F., Echinard-Garin P., Lascaux V., Poupon M. F. Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet. Anticancer Res. 1987 Jul-Aug;7(4B):861–867. [PubMed] [Google Scholar]
  6. Colombani F., Cherest H., de Robichon-Szulmajster H. Biochemical and regulatory effects of methionine analogues in Saccharomyces cerevisiae. J Bacteriol. 1975 May;122(2):375–384. doi: 10.1128/jb.122.2.375-384.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cox R., Irving C. C. Inhibition of DNA methylation by S-adenosylethionine with the production of methyl-deficient DNA in regenerating rat liver. Cancer Res. 1977 Jan;37(1):222–225. [PubMed] [Google Scholar]
  8. Crawford E. D., Eisenberger M. A., McLeod D. G., Spaulding J. T., Benson R., Dorr F. A., Blumenstein B. A., Davis M. A., Goodman P. J. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med. 1989 Aug 17;321(7):419–424. doi: 10.1056/NEJM198908173210702. [DOI] [PubMed] [Google Scholar]
  9. Fiskerstrand T., Christensen B., Tysnes O. B., Ueland P. M., Refsum H. Development and reversion of methionine dependence in a human glioma cell line: relation to homocysteine remethylation and cobalamin status. Cancer Res. 1994 Sep 15;54(18):4899–4906. [PubMed] [Google Scholar]
  10. Guo H. Y., Herrera H., Groce A., Hoffman R. M. Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res. 1993 Jun 1;53(11):2479–2483. [PubMed] [Google Scholar]
  11. Guo H. Y., Hoffman R. M., Herrera H. Unchecked DNA synthesis and blocked cell division induced by methionine deprivation in a human prostate cancer cell line. In Vitro Cell Dev Biol Anim. 1993 May;29A(5):359–361. doi: 10.1007/BF02633982. [DOI] [PubMed] [Google Scholar]
  12. Guo H., Lishko V. K., Herrera H., Groce A., Kubota T., Hoffman R. M. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res. 1993 Dec 1;53(23):5676–5679. [PubMed] [Google Scholar]
  13. Hoffman R. M., Erbe R. W. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci U S A. 1976 May;73(5):1523–1527. doi: 10.1073/pnas.73.5.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hoffman R. M., Jacobsen S. J. Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7306–7310. doi: 10.1073/pnas.77.12.7306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Judde J. G., Ellis M., Frost P. Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res. 1989 Sep 1;49(17):4859–4865. [PubMed] [Google Scholar]
  16. Kaighn M. E., Narayan K. S., Ohnuki Y., Lechner J. F., Jones L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979 Jul;17(1):16–23. [PubMed] [Google Scholar]
  17. Kim H. J., Balcezak T. J., Nathin S. J., McMullen H. F., Hansen D. E. The use of a spectrophotometric assay to study the interaction of S-adenosylmethionine synthetase with methionine analogues. Anal Biochem. 1992 Nov 15;207(1):68–72. doi: 10.1016/0003-2697(92)90501-w. [DOI] [PubMed] [Google Scholar]
  18. Kramer D. L., Porter C. W., Borchardt R. T., Sufrin J. R. Combined modulation of S-adenosylmethionine biosynthesis and S-adenosylhomocysteine metabolism enhances inhibition of nucleic acid methylation and L1210 cell growth. Cancer Res. 1990 Jul 1;50(13):3838–3842. [PubMed] [Google Scholar]
  19. LEVINE M., TARVER H. Studies on ethionine. III. Incorporation of ethionine into rat proteins. J Biol Chem. 1951 Oct;192(2):835–850. [PubMed] [Google Scholar]
  20. Lasserre C., Sabatier L., Beaumatin J., Luccioni C., Lefrançois D., Muleris M., Dutrillaux B. Gene dosage and expression, and enzyme activity of thymidine kinase and thymidylate synthase in xenografted colorectal adenocarcinomas. Int J Cancer. 1994 Feb 15;56(4):506–511. doi: 10.1002/ijc.2910560409. [DOI] [PubMed] [Google Scholar]
  21. Liteplo R. G., Hipwell S. E., Rosenblatt D. S., Sillaots S., Lue-Shing H. Changes in cobalamin metabolism are associated with the altered methionine auxotrophy of highly growth autonomous human melanoma cells. J Cell Physiol. 1991 Nov;149(2):332–338. doi: 10.1002/jcp.1041490222. [DOI] [PubMed] [Google Scholar]
  22. Mecham J. O., Rowitch D., Wallace C. D., Stern P. H., Hoffman R. M. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun. 1983 Dec 16;117(2):429–434. doi: 10.1016/0006-291x(83)91218-4. [DOI] [PubMed] [Google Scholar]
  23. Miccoli L., Oudard S., Sureau F., Poirson F., Dutrillaux B., Poupon M. F. Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. Biochem J. 1996 Feb 1;313(Pt 3):957–962. doi: 10.1042/bj3130957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ogier G., Chantepie J., Deshayes C., Chantegrel B., Charlot C., Doutheau A., Quash G. Contribution of 4-methylthio-2-oxobutanoate and its transaminase to the growth of methionine-dependent cells in culture. Effect of transaminase inhibitors. Biochem Pharmacol. 1993 Apr 22;45(8):1631–1644. doi: 10.1016/0006-2952(93)90304-f. [DOI] [PubMed] [Google Scholar]
  25. Oudard S., Poirson F., Miccoli L., Bourgeois Y., Vassault A., Poisson M., Magdelénat H., Dutrillaux B., Poupon M. F. Mitochondria-bound hexokinase as target for therapy of malignant gliomas. Int J Cancer. 1995 Jul 17;62(2):216–222. doi: 10.1002/ijc.2910620218. [DOI] [PubMed] [Google Scholar]
  26. Pezacka E. H., Jacobsen D. W., Luce K., Green R. Glial cells as a model for the role of cobalamin in the nervous system: impaired synthesis of cobalamin coenzymes in cultured human astrocytes following short-term cobalamin-deprivation. Biochem Biophys Res Commun. 1992 Apr 30;184(2):832–839. doi: 10.1016/0006-291x(92)90665-8. [DOI] [PubMed] [Google Scholar]
  27. Poupon M. F., Arvelo F., Goguel A. F., Bourgeois Y., Jacrot M., Hanania N., Arriagada R., Le Chevalier T. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. J Natl Cancer Inst. 1993 Dec 15;85(24):2023–2029. doi: 10.1093/jnci/85.24.2023. [DOI] [PubMed] [Google Scholar]
  28. Redgate E. S., Boggs S., Grudziak A., Deutsch M. Polyamines in brain tumor therapy. J Neurooncol. 1995;25(2):167–179. doi: 10.1007/BF01057761. [DOI] [PubMed] [Google Scholar]
  29. Stern P. H., Hoffman R. M. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst. 1986 Apr;76(4):629–639. doi: 10.1093/jnci/76.4.629. [DOI] [PubMed] [Google Scholar]
  30. WARBURG O. On the origin of cancer cells. Science. 1956 Feb 24;123(3191):309–314. doi: 10.1126/science.123.3191.309. [DOI] [PubMed] [Google Scholar]
  31. Wingo P. A., Tong T., Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995 Jan-Feb;45(1):8–30. doi: 10.3322/canjclin.45.1.8. [DOI] [PubMed] [Google Scholar]
  32. Wyllie A. H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev. 1992 Sep;11(2):95–103. doi: 10.1007/BF00048057. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES